MedTrace Logo

Novel Biophotonics Methodology for Colon Cancer Screening

NCT01999478 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2016-06-13

No results posted yet for this study

Summary

The study is testing a new, safe and effective way for the early detection of colon cancer. The method uses Low-coherence Enhanced Backscattering Spectroscopy (LEBS). This is an optic probe which is a small device that uses light (not laser) to assess the colon lining. This probe will be used before colonoscopy to identify subjects who do and do not have precancerous changes in the colon by capturing the light reflected back from the rectal wall and that will be assessed without the need for colonoscopy and bowel preparation (colon cleaning). This device may detect early cancerous changes in colon tissue with higher accuracy than current tests.

Conditions

Sponsors & Collaborators

  • Boston Medical Center

    lead OTHER

Principal Investigators

  • Vadim Backman, PhD · Northwestern University

  • Hemant Roy, MD · Boston University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01999478 on ClinicalTrials.gov